ReviewInnere Medizin (Heidelberg, Germany)2026
[Atrial fibrillation screening-reading the P-wave].
Review in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) is frequently intermittent and may therefore remain undetected on a short resting electrocardiogram (ECG). At the same time, a sinus-rhythm ECG contains information on the underlying atrial substrate.
objectiveTo review conventional and artificial intelligence (AI)-based ECG markers of an atrial risk phenotype and their potential role in targeted AF screening. MATERIALS AND
methodsNarrative appraisal of current consensus and guideline documents and of clinical, electrophysiological, and population-based studies on P‑wave parameters, AI-ECG, and risk-adapted AF screening.
resultsP‑wave duration, interatrial block, P‑wave terminal force in V1, and other parameters are associated with atrial remodelling and future AF. AI models additionally extract high-dimensional patterns from sinus-rhythm ECGs and can predict occult or future AF. Initial prospective data indicate that such risk signals can enrich the diagnostic yield of prolonged rhythm monitoring.
conclusionThe most plausible current clinical application is risk-adapted selection for prolonged rhythm monitoring. A P-wave or AI-based risk score neither establishes a diagnosis of AF nor, by itself, constitutes an indication for treatment.
Indexed as
Identifiers
42827193What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.